nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Dactinomycin—sarcoma	0.143	0.176	CbGbCtD
Atazanavir—ABCC1—Mitoxantrone—sarcoma	0.128	0.158	CbGbCtD
Atazanavir—ABCC1—Epirubicin—sarcoma	0.104	0.128	CbGbCtD
Atazanavir—ABCC1—Vincristine—sarcoma	0.0883	0.108	CbGbCtD
Atazanavir—ABCC1—Etoposide—sarcoma	0.0809	0.0994	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—sarcoma	0.0552	0.0678	CbGbCtD
Atazanavir—CYP3A4—Thiotepa—sarcoma	0.0432	0.053	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—sarcoma	0.0346	0.0425	CbGbCtD
Atazanavir—ABCB1—Mitoxantrone—sarcoma	0.031	0.038	CbGbCtD
Atazanavir—ABCB1—Vincristine—sarcoma	0.0213	0.0262	CbGbCtD
Atazanavir—ABCB1—Etoposide—sarcoma	0.0195	0.024	CbGbCtD
Atazanavir—CYP3A4—Mitoxantrone—sarcoma	0.0186	0.0228	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—sarcoma	0.0133	0.0164	CbGbCtD
Atazanavir—CYP3A4—Vincristine—sarcoma	0.0128	0.0157	CbGbCtD
Atazanavir—CYP3A4—Etoposide—sarcoma	0.0117	0.0144	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—sarcoma	0.00798	0.0098	CbGbCtD
Atazanavir—Cardiac arrest—Doxorubicin—sarcoma	0.000203	0.00109	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—sarcoma	0.000202	0.00109	CcSEcCtD
Atazanavir—Asthenia—Thiotepa—sarcoma	0.000202	0.00109	CcSEcCtD
Atazanavir—Infection—Etoposide—sarcoma	0.000201	0.00108	CcSEcCtD
Atazanavir—Abdominal distension—Epirubicin—sarcoma	0.000201	0.00108	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—sarcoma	0.0002	0.00108	CcSEcCtD
Atazanavir—Feeling abnormal—Mitoxantrone—sarcoma	0.0002	0.00108	CcSEcCtD
Atazanavir—Pruritus—Thiotepa—sarcoma	0.000199	0.00107	CcSEcCtD
Atazanavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000199	0.00107	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—sarcoma	0.000198	0.00107	CcSEcCtD
Atazanavir—Eosinophilia—Epirubicin—sarcoma	0.000197	0.00106	CcSEcCtD
Atazanavir—Abdominal pain—Vincristine—sarcoma	0.000197	0.00106	CcSEcCtD
Atazanavir—Body temperature increased—Vincristine—sarcoma	0.000197	0.00106	CcSEcCtD
Atazanavir—Skin disorder—Etoposide—sarcoma	0.000196	0.00106	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—sarcoma	0.000196	0.00105	CcSEcCtD
Atazanavir—Hyperhidrosis—Etoposide—sarcoma	0.000195	0.00105	CcSEcCtD
Atazanavir—Pancreatitis—Epirubicin—sarcoma	0.000195	0.00105	CcSEcCtD
Atazanavir—Urticaria—Mitoxantrone—sarcoma	0.000193	0.00104	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—sarcoma	0.000193	0.00104	CcSEcCtD
Atazanavir—Anorexia—Etoposide—sarcoma	0.000193	0.00104	CcSEcCtD
Atazanavir—Diarrhoea—Thiotepa—sarcoma	0.000193	0.00104	CcSEcCtD
Atazanavir—Abdominal pain—Mitoxantrone—sarcoma	0.000192	0.00103	CcSEcCtD
Atazanavir—Body temperature increased—Mitoxantrone—sarcoma	0.000192	0.00103	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000192	0.00103	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—sarcoma	0.000191	0.00103	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—sarcoma	0.000191	0.00103	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—sarcoma	0.000189	0.00102	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000188	0.00101	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—sarcoma	0.000188	0.00101	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—sarcoma	0.000186	0.001	CcSEcCtD
Atazanavir—Dizziness—Thiotepa—sarcoma	0.000186	0.001	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—sarcoma	0.000186	0.000998	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—sarcoma	0.000184	0.00099	CcSEcCtD
Atazanavir—Hypersensitivity—Vincristine—sarcoma	0.000184	0.000989	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—sarcoma	0.000183	0.000982	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—sarcoma	0.000182	0.000978	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—sarcoma	0.000181	0.000976	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—sarcoma	0.000181	0.000972	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—sarcoma	0.00018	0.00097	CcSEcCtD
Atazanavir—Dyspnoea—Etoposide—sarcoma	0.00018	0.000969	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—sarcoma	0.00018	0.000967	CcSEcCtD
Atazanavir—Somnolence—Etoposide—sarcoma	0.00018	0.000967	CcSEcCtD
Atazanavir—Hypersensitivity—Mitoxantrone—sarcoma	0.000179	0.000963	CcSEcCtD
Atazanavir—Asthenia—Vincristine—sarcoma	0.000179	0.000963	CcSEcCtD
Atazanavir—Vomiting—Thiotepa—sarcoma	0.000179	0.000963	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—sarcoma	0.000178	0.000955	CcSEcCtD
Atazanavir—Rash—Thiotepa—sarcoma	0.000177	0.000955	CcSEcCtD
Atazanavir—Dermatitis—Thiotepa—sarcoma	0.000177	0.000954	CcSEcCtD
Atazanavir—Headache—Thiotepa—sarcoma	0.000176	0.000948	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000176	0.000948	CcSEcCtD
Atazanavir—Rash—Dactinomycin—sarcoma	0.000176	0.000947	CcSEcCtD
Atazanavir—Decreased appetite—Etoposide—sarcoma	0.000176	0.000945	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—sarcoma	0.000175	0.000939	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Etoposide—sarcoma	0.000175	0.000939	CcSEcCtD
Atazanavir—Asthenia—Mitoxantrone—sarcoma	0.000174	0.000938	CcSEcCtD
Atazanavir—Fatigue—Etoposide—sarcoma	0.000174	0.000938	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—sarcoma	0.000174	0.000937	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—sarcoma	0.000173	0.000932	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—sarcoma	0.000173	0.000932	CcSEcCtD
Atazanavir—Pain—Etoposide—sarcoma	0.000173	0.00093	CcSEcCtD
Atazanavir—Constipation—Etoposide—sarcoma	0.000173	0.00093	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—sarcoma	0.000173	0.000929	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—sarcoma	0.000172	0.000927	CcSEcCtD
Atazanavir—Diarrhoea—Vincristine—sarcoma	0.000171	0.000918	CcSEcCtD
Atazanavir—Sweating—Epirubicin—sarcoma	0.00017	0.000916	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—sarcoma	0.00017	0.000916	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—sarcoma	0.000169	0.000911	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—sarcoma	0.000168	0.000905	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—sarcoma	0.000168	0.000904	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—sarcoma	0.000168	0.000903	CcSEcCtD
Atazanavir—Nausea—Thiotepa—sarcoma	0.000167	0.000899	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—sarcoma	0.000167	0.000897	CcSEcCtD
Atazanavir—Feeling abnormal—Etoposide—sarcoma	0.000167	0.000896	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—sarcoma	0.000166	0.000895	CcSEcCtD
Atazanavir—Diarrhoea—Mitoxantrone—sarcoma	0.000166	0.000894	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—sarcoma	0.000166	0.000892	CcSEcCtD
Atazanavir—Gastrointestinal pain—Etoposide—sarcoma	0.000165	0.000889	CcSEcCtD
Atazanavir—Dizziness—Vincristine—sarcoma	0.000165	0.000888	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000163	0.000877	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—sarcoma	0.000162	0.000869	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—sarcoma	0.000161	0.000867	CcSEcCtD
Atazanavir—Urticaria—Etoposide—sarcoma	0.000161	0.000864	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—sarcoma	0.00016	0.000862	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—sarcoma	0.00016	0.000862	CcSEcCtD
Atazanavir—Abdominal pain—Etoposide—sarcoma	0.00016	0.00086	CcSEcCtD
Atazanavir—Body temperature increased—Etoposide—sarcoma	0.00016	0.00086	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—sarcoma	0.00016	0.00086	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—sarcoma	0.00016	0.000858	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—sarcoma	0.000159	0.000854	CcSEcCtD
Atazanavir—Vomiting—Vincristine—sarcoma	0.000159	0.000854	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—sarcoma	0.000158	0.000848	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—sarcoma	0.000158	0.000847	CcSEcCtD
Atazanavir—Rash—Vincristine—sarcoma	0.000157	0.000846	CcSEcCtD
Atazanavir—Dermatitis—Vincristine—sarcoma	0.000157	0.000846	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—sarcoma	0.000157	0.000845	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—sarcoma	0.000157	0.000843	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—sarcoma	0.000157	0.000843	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—sarcoma	0.000156	0.000841	CcSEcCtD
Atazanavir—Headache—Vincristine—sarcoma	0.000156	0.000841	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000156	0.000836	CcSEcCtD
Atazanavir—Vomiting—Mitoxantrone—sarcoma	0.000155	0.000831	CcSEcCtD
Atazanavir—Rash—Mitoxantrone—sarcoma	0.000153	0.000824	CcSEcCtD
Atazanavir—Dermatitis—Mitoxantrone—sarcoma	0.000153	0.000824	CcSEcCtD
Atazanavir—Headache—Mitoxantrone—sarcoma	0.000152	0.000819	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—sarcoma	0.000151	0.000811	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—sarcoma	0.000149	0.000802	CcSEcCtD
Atazanavir—Hypersensitivity—Etoposide—sarcoma	0.000149	0.000801	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—sarcoma	0.000149	0.0008	CcSEcCtD
Atazanavir—Nausea—Vincristine—sarcoma	0.000148	0.000797	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—sarcoma	0.000148	0.000796	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—sarcoma	0.000148	0.000794	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—sarcoma	0.000147	0.00079	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—sarcoma	0.000146	0.000784	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—sarcoma	0.000145	0.000782	CcSEcCtD
Atazanavir—Asthenia—Etoposide—sarcoma	0.000145	0.00078	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—sarcoma	0.000145	0.00078	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—sarcoma	0.000145	0.000778	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—sarcoma	0.000145	0.000778	CcSEcCtD
Atazanavir—Nausea—Mitoxantrone—sarcoma	0.000144	0.000777	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—sarcoma	0.000144	0.000775	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—sarcoma	0.000144	0.000773	CcSEcCtD
Atazanavir—Pruritus—Etoposide—sarcoma	0.000143	0.000769	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—sarcoma	0.000141	0.000758	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—sarcoma	0.00014	0.000752	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—sarcoma	0.00014	0.000751	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—sarcoma	0.000139	0.000747	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—sarcoma	0.000138	0.000744	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—sarcoma	0.000138	0.000742	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—sarcoma	0.000138	0.00074	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—sarcoma	0.000137	0.000737	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—sarcoma	0.000137	0.000736	CcSEcCtD
Atazanavir—Tension—Epirubicin—sarcoma	0.000136	0.000733	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—sarcoma	0.000136	0.000731	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—sarcoma	0.000135	0.000725	CcSEcCtD
Atazanavir—Back pain—Epirubicin—sarcoma	0.000134	0.000722	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—sarcoma	0.000134	0.00072	CcSEcCtD
Atazanavir—Dizziness—Etoposide—sarcoma	0.000134	0.000719	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—sarcoma	0.000133	0.000717	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—sarcoma	0.000133	0.000715	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—sarcoma	0.00013	0.000702	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—sarcoma	0.000129	0.000696	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—sarcoma	0.000129	0.000693	CcSEcCtD
Atazanavir—Vomiting—Etoposide—sarcoma	0.000129	0.000691	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—sarcoma	0.000129	0.000691	CcSEcCtD
Atazanavir—Agitation—Epirubicin—sarcoma	0.000128	0.000686	CcSEcCtD
Atazanavir—Rash—Etoposide—sarcoma	0.000127	0.000686	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—sarcoma	0.000127	0.000685	CcSEcCtD
Atazanavir—Headache—Etoposide—sarcoma	0.000127	0.000681	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—sarcoma	0.000127	0.000681	CcSEcCtD
Atazanavir—Tension—Doxorubicin—sarcoma	0.000126	0.000678	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—sarcoma	0.000126	0.000677	CcSEcCtD
Atazanavir—Malaise—Epirubicin—sarcoma	0.000125	0.000674	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—sarcoma	0.000125	0.000671	CcSEcCtD
Atazanavir—Syncope—Epirubicin—sarcoma	0.000125	0.00067	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—sarcoma	0.000124	0.000668	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—sarcoma	0.000123	0.00066	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—sarcoma	0.000122	0.000656	CcSEcCtD
Atazanavir—Cough—Epirubicin—sarcoma	0.000121	0.000652	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—sarcoma	0.00012	0.000647	CcSEcCtD
Atazanavir—Nausea—Etoposide—sarcoma	0.00012	0.000646	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—sarcoma	0.00012	0.000645	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—sarcoma	0.000119	0.000641	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—sarcoma	0.000118	0.000636	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—sarcoma	0.000118	0.000636	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—sarcoma	0.000118	0.000636	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—sarcoma	0.000118	0.000635	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—sarcoma	0.000118	0.000634	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000117	0.000631	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—sarcoma	0.000117	0.000628	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—sarcoma	0.000116	0.000623	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—sarcoma	0.000116	0.000622	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—sarcoma	0.000115	0.00062	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—sarcoma	0.000114	0.000615	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—sarcoma	0.000114	0.000611	CcSEcCtD
Atazanavir—Oedema—Epirubicin—sarcoma	0.000113	0.00061	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—sarcoma	0.000113	0.000607	CcSEcCtD
Atazanavir—Infection—Epirubicin—sarcoma	0.000113	0.000606	CcSEcCtD
Atazanavir—Cough—Doxorubicin—sarcoma	0.000112	0.000603	CcSEcCtD
Atazanavir—Shock—Epirubicin—sarcoma	0.000112	0.0006	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—sarcoma	0.000111	0.000599	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—sarcoma	0.000111	0.000598	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—sarcoma	0.000111	0.000597	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—sarcoma	0.00011	0.000592	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—sarcoma	0.00011	0.000589	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—sarcoma	0.000109	0.000588	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—sarcoma	0.000109	0.000588	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—sarcoma	0.000109	0.000588	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—sarcoma	0.000109	0.000586	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000109	0.000584	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—sarcoma	0.000108	0.000581	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—sarcoma	0.000108	0.000581	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—sarcoma	0.000107	0.000575	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—sarcoma	0.000106	0.000569	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—sarcoma	0.000105	0.000564	CcSEcCtD
Atazanavir—Infection—Doxorubicin—sarcoma	0.000104	0.00056	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000103	0.000555	CcSEcCtD
Atazanavir—Shock—Doxorubicin—sarcoma	0.000103	0.000555	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—sarcoma	0.000103	0.000553	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—sarcoma	0.000103	0.000551	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—sarcoma	0.000102	0.000548	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—sarcoma	0.000101	0.000545	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—sarcoma	0.000101	0.000543	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—sarcoma	0.000101	0.000542	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—sarcoma	0.0001	0.000538	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—sarcoma	9.98e-05	0.000537	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—sarcoma	9.85e-05	0.00053	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—sarcoma	9.79e-05	0.000526	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—sarcoma	9.77e-05	0.000526	CcSEcCtD
Atazanavir—Pain—Epirubicin—sarcoma	9.69e-05	0.000521	CcSEcCtD
Atazanavir—Constipation—Epirubicin—sarcoma	9.69e-05	0.000521	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—sarcoma	9.56e-05	0.000514	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—sarcoma	9.49e-05	0.00051	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—sarcoma	9.35e-05	0.000503	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—sarcoma	9.34e-05	0.000502	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—sarcoma	9.32e-05	0.000501	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—sarcoma	9.27e-05	0.000498	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—sarcoma	9.23e-05	0.000496	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—sarcoma	9.12e-05	0.00049	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—sarcoma	9.05e-05	0.000487	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—sarcoma	9.04e-05	0.000486	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—sarcoma	9e-05	0.000484	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—sarcoma	8.97e-05	0.000482	CcSEcCtD
Atazanavir—Pain—Doxorubicin—sarcoma	8.97e-05	0.000482	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—sarcoma	8.96e-05	0.000482	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—sarcoma	8.96e-05	0.000482	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—sarcoma	8.64e-05	0.000465	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—sarcoma	8.58e-05	0.000461	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—sarcoma	8.35e-05	0.000449	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—sarcoma	8.33e-05	0.000448	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—sarcoma	8.29e-05	0.000446	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—sarcoma	8.29e-05	0.000446	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—sarcoma	8.13e-05	0.000437	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—sarcoma	8.02e-05	0.000431	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—sarcoma	7.76e-05	0.000417	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—sarcoma	7.73e-05	0.000416	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—sarcoma	7.52e-05	0.000405	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—sarcoma	7.5e-05	0.000403	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—sarcoma	7.42e-05	0.000399	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—sarcoma	7.21e-05	0.000388	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—sarcoma	7.18e-05	0.000386	CcSEcCtD
Atazanavir—Rash—Epirubicin—sarcoma	7.15e-05	0.000384	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—sarcoma	7.14e-05	0.000384	CcSEcCtD
Atazanavir—Headache—Epirubicin—sarcoma	7.1e-05	0.000382	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—sarcoma	6.94e-05	0.000373	CcSEcCtD
Atazanavir—Nausea—Epirubicin—sarcoma	6.73e-05	0.000362	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—sarcoma	6.67e-05	0.000359	CcSEcCtD
Atazanavir—Rash—Doxorubicin—sarcoma	6.61e-05	0.000356	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—sarcoma	6.61e-05	0.000355	CcSEcCtD
Atazanavir—Headache—Doxorubicin—sarcoma	6.57e-05	0.000353	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—sarcoma	6.23e-05	0.000335	CcSEcCtD
